When pharmaceutical companies miss their capacity forecast, it is both costly and time consuming, so many are choosing to outsource in order to mitigate risks.
Drug companies should share more details of their APIs and the green credentials of the companies that supply says an award winning environmental researcher.
The partnership with recombinant protein development firm GTP Technologies will create an end-to-end manufacturing service, speeding up production of monoclonal antibodies and reducing costs, says Novasep.
The global contract and manufacturing organization (CDMO) announced the construction at a ground breaking ceremony held at its Ravensburg Schuetzenstrasse site.